Recovery From Sarcoidosis to be Highlighted at Conference March 12-13, 2005 The Autoimmunity Research Foundation is sponsoring a conference March 12-13, 2005, at ChicagoÂs Midway Airport, that will bring together physicians, recovering patients and policy-makers to review an innovative antibacterial therapy that offers hope for effective treatment of several autoimmune diseases including: Sarcoidosis (Reggie WhiteÂs disease). Thousand Oaks, CA (PRWEB) February 21, 2005 The Autoimmunity Research Foundation is sponsoring a conference March 12-13, 2005, at ChicagoÂs Midway Airport, that will bring together physicians, recovering patients and policy-makers to review an innovative antibacterial therapy that offers hope for effective treatment of several autoimmune diseases including: Sarcoidosis (Reggie WhiteÂs disease), Chronic Fatigue Syndrome, Chronic Lyme Disease, Rheumatoid Arthritis and Fibromyalgia. The recent death of Reggie White has sparked a national interest in Sarcoidosis. Actors Bernie Mac, Tisha Campbell-Martin and former NBA star Bill Russell have recently announced they are battling this disease. Sudden death from Sarcoidosis is not as rare as once thought and sometimes the disease is not diagnosed until after death. ChicagoÂs NBC sports anchor, Darrian Chapman, died suddenly of cardiac Sarcoidosis two years ago. Dr. Mark Rosenthal, a nationally recognized Philadelphia cardiologist, died of sudden cardiac arrhythmia due to Sarcoidosis four years ago. Now it seems that a cure may be on the horizon. This conference will bring together a pioneering group of Sarcoidosis patients and physicians who have shown that it is possible to return to health using a combination of common antibiotics. The treatment for Sarcoidosis has not changed in fifty years. Patients are allowed to deteriorate without treatment until they are so ill or have enough major organ damage to warrant the use of prednisone, a drug that is not effective at halting the disease, but which can provide short-term relief. Many doctors believe the widespread myth that Sarcoidosis may go away without treatment. However, the recent national NIH study of Sarcoidosis, ACCESS, conclusively proved that this is not true. This study of Sarcoidosis, the largest ever conducted, revealed that the disease does not resolve on its own, whether treated with prednisone or not. The ACCESS study noted, "Most patients with persistent disease at two years were unlikely to have resolution of Sarcoidosis" and "end stage pulmonary Sarcoidosis usually develops over one or two decades." The sad tragedy of this disease is that studies dating back to 1972 have been showing that species of bacteria including Mycobacteria, Rickettsia, Borrelia and Propionibacteria are somehow associated with Sarcoidosis. Yet these studies have been largely ignored. Trevor Marshall, Ph.D., an Autoimmunity Research Foundation director, commented, "Some years ago, we discovered that the bacteria causing these diseases are resistant to antibiotics unless care is taken to reduce two hormones in the bodyÂs endocrine system  Angiotensin II and 1,25-dihydroxycholecalciferol. That was the breakthrough in understanding these diseases." This conference brings together this first-ever group of patients to recover from Sarcoidosis, and many of their physicians, with policy makers from the National Institutes of Health (NIH) and the FDA. A few online registrations are still open for interested patients and physicians at URL: http://autoimmunityresearch.org/chicago2005.htm Press passes are available. Conference speakers will include:
Contact: Belinda Fenter Autoimmunity Research Foundation 817-732-7336 Email: belindaf@autoimmunityresearch.org http://www.autoimmunityresearch.org # # #
|
© Copyright 1997-2012, Vocus PRW Holdings, LLC. |